期刊文献+

PCNA、MMP9和E-cd在膀胱移行上皮癌中表达及意义 被引量:5

Expression and Significance of PCNA, MMP9 and E-cd in Transitional Cell Carcinoma of Bladder
下载PDF
导出
摘要 目的:探讨PCNA、MMP9和E-cd在膀胱移行细胞癌(BTCC)中的表达及意义。方法:用免疫组织化学方法检测73例BTCC及11例正常膀胱黏膜中PCNA、MMP9和E-cd的表达。结果:PCNA、MMP9和E-cd在正常膀胱黏膜与不同病理分级和临床分期的BTCC中的表达有显著性差异。MMP9、PCNA的阳性表达随着BTCC病理分级和临床分期的升高而增高。E-cd的阳性表达率随着肿瘤的病理分级和临床分期的升高而降低。PCNA、MMP9和E-cd两两之间在BTCC中的表达亦有显著性差异(P<0.05或P<0.01)。结论:PCNA、MMP9和E-cd的表达,与BTCC的生物学行为关系密切,并可多因素参与膀胱癌的生物学行为。 Objective To study the expression and significance of PCNA MMP9 and E-cd in transitional cell carcinoma of bladder BTCC. Methods The immunohistochemical stainning method was used to evaluate the PCNA MMP9 and E-cd in 73 cases of transitional cell carcinoma of bladder. Results The positive rates of these three expression products were as follows 60.3%PCNA 27.4%MMP9 and 56.2%E-cd. The expressions of PCNA and MMP9 were found to be positively correlated to the pathological grade and the clinical staging of BTCC. The expression of E-cd was found to be negatively correlated to pathological grade and the clinical staging of BTCC. Conclusion The results suggest that PCNA MMP9 and E-cd play important roles in the occurrence and development of BTCC. Multiple factors are assayed for pathological diagnosis prognosis and treatment in BTCC.
出处 《天津医药》 CAS 北大核心 2005年第7期405-407,共3页 Tianjin Medical Journal
关键词 PCNA 膀胱移行上皮癌 表达及 cd 免疫组织化学方法 膀胱移行细胞癌 MMP9 BTCC 显著性差异 临床分期 病理分级 膀胱黏膜 阳性表达率 生物学行为 0.05 行为关系 膀胱癌 多因素 升高 carcinoma  transitional cell proliferating cell nuclear antigen cadherins gelatinase B immunohistochemistry
  • 相关文献

参考文献9

  • 1Hsieh JT, Dinney CP, Chung LW. The potential role of gene therapy in the treatment of bladder cancer. Uro Clin N Am, 2000,27(1): 103-113.
  • 2Taftachi R, Ayhan A, Ekici S, et al. Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67. BJU Int, 2005,95(4):650-654.
  • 3Bozlu M, Orhan D, Baltaci S, et al. The prognostic value of proliferating cell nuclear antigen, Ki-67 and nucleolar organizer region in transitional cell carcinoma of the bladder. Int Urol Nephrol, 2002,33(1):59-66.
  • 4Hiroaki S, Mikio L, Haruhiko N, et al. Immunochistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of bladder.Caneer, 1996,78 (8): 1762-1766.
  • 5Morgan H, Hill PA. Human breast cancer cell-mediated bone collagen degradation requires plasminogen activation and matrix metalloproteinase activity. Cancer Cell Int, 2005,5(1): 1-5.
  • 6Ozdemir E, Kakehi Y, Okuno H, et al.Role of matrix metalloproteinase-9 in the basement membrance destruction of superficial urothelial carcinoma. J Urol,1999,161(4):1359-1363.
  • 7Harrison OJ, Corps EM, Berge T, et al. The mechanism of cell adhesion by classical cadherins: the role of domain 1. J Cell Sci,2005, 118(Pt 4):711-721.
  • 8Nabeshima K, Inoue T, Shimao Y,et al.Cohort migration of carcinoma cells:differentiated colorectal carcinoma cells move as coherent cell clusters or sheets. Histol Histopathol, 1999,14(4): 1183 - 1187.
  • 9Imao T, Koshida K, Endo Y, et al. Namiki M. Dominant role of Ecadherin in the progression of bladder cancer. J Urol, 1999, 161(2):692-698.

同被引文献72

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部